IL37 and autoimmune disease: Nonetheless, even though it is inconsistent with the potent anti-inflammatory action of IL37 in experimental studies, the hypothesis can neither be ruled out that the augmented levels of IL37 may play an unexpected pathogenetic role in these autoimmune diseases by activating unknown inflammatory pathways that have so far not been recognized to be modulated by IL37.